Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menitorix Immunogenicity in UK Lab Workers
NCT00503165Phase 4Completed
- Sponsor
- UK Health Security Agency
- Start
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Hib-MenC-TT in Serogroup C meningococcal disease (MenC), Haemophilus influenzae type b infection (Hib), sponsored by UK Health Security Agency. Started Jul 2007; status: completed.
02
Drugs
Hib-MenC-TT
03
Conditions
Serogroup C meningococcal disease (MenC)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00503165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503165.